Amyloid-beta peptide, oxidative stress and inflammation in Alzheimer's disease: Potential neuroprotective effects of omega-3 polyunsaturated fatty acids

This source preferred by Simon Dyall

Authors: Dyall, S.C.

http://eprints.bournemouth.ac.uk/21699/

Journal: International Journal of Alzheimer's Disease Article

Pages: ID 274128

This data was imported from Scopus:

Authors: Dyall, S.C.

http://eprints.bournemouth.ac.uk/21699/

Journal: International Journal of Alzheimer's Disease

eISSN: 2090-0252

DOI: 10.4061/2010/274128

Alzheimer's disease is the most common form of dementia in the elderly and is a progressive neurodegenerative disorder characterised by a decline in cognitive function and also profound alterations in mood and behaviour. The pathology of the disease is characterised by the presence of extracellular amyloid peptide deposits and intracellular neurofibrillary tangles in the brain. Although many hypotheses have been put forward for the aetiology of the disease, increased inflammation and oxidative stress appear key to be features contributing to the pathology. The omega-3 polyunsaturated f ats, eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) have well-characterised effects on inflammation and may have neuroprotective effects in a number of neurodegenerative conditions including Alzheimer's disease. The aims of this paper are to review the neuroprotective effects of EPA and DHA in Alzheimer's disease, with special emphasis on their role in modulating oxidative stress and inflammation and also examine their potential as therapeutic agents. Copyright © 2010 S. C. Dyall.

The data on this page was last updated at 04:52 on May 26, 2018.